首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Extracellular ATP induces cell death in CD4+/CD8+ double-positive thymocytes in mice infected with Trypanosoma cruzi
Authors:Mantuano-Barradas Marcio  Henriques-Pons Andréa  Araújo-Jorge Tânia C  Di Virgilio Francesco  Coutinho-Silva Robson  Persechini Pedro M
Institution:1. Laboratório de Imunobiofísica, Instituto de Biofísica Carlos Chagas Filho, UFRJ, Bloco G do CCS, Cidade Universitária, Ilha do Fundão, 21941-590 Rio de Janeiro, Brazil;2. Laboratório de Biologia Celular, DUBC, Instituto Oswaldo Cruz FIOCRUZ, Rio de Janeiro, Manguinhos 21045-900, Brazil;3. Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara-44100, Italy
Abstract:In the acute phase of Trypanosoma cruzi infection, there is dramatic atrophy of the thymus. However, the pathways involved in this change have not yet been identified. This event is mainly characterized by a massive loss of cortical CD4+/CD8+ double-positive cells, but also by other structural and functional alterations in the organ. A number of molecules, including extracellular ATP, have been suggested to play a role in the selective processes that take place in the thymus. ATP and analogues trigger many different cellular responses in thymocytes and other cell types, such as the opening of plasma membrane cation channels and a pore that may induce cell death. Herein, we investigated the possible involvement of extracellular ATP in thymus atrophy induced by infection with T. cruzi. We observed that ATP induces an increase in plasma membrane permeabilization and cellular death in CD4+/CD8+ double-positive thymocytes collected from infected mice during the atrophy phase. No differences were observed prior to the atrophy phase or during the chronic phase. Our results indicate that P2Z/P2X7 receptors may play a central role in thymus atrophy during T. cruzi infection.
Keywords:Nucleotide receptor  Thymus  Trypanosoma cruzi  Atrophy  ATP  P2X7
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号